In this issue of Cardiology Clinics, guest editors Drs. Eric H. Yang and Ashley F. Stein-Merlob bring their considerable expertise to the topic of Cardio-oncology. Top experts discuss key topics such as anthracycline-induced cardiotoxicity; cardiac complications of immunotherapy:: immune checkpoint inhibitors and CAR T cell therapy; advances in diagnosis and treatment of amyloid cardiomyopathy; guidelines in cardio-oncology; and more.
Cardiovascular Risk Assessment and Prevention in Cardio-Oncology: Beyond Traditional Risk Factors Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Health Unique Challenges of Adult Congenital Heart Disease in Cardio-Oncology Classes of Antineoplastic Agents Associated with Increased Risk of Cancer Therapy-associated Hypertension and Management Strategies Arrhythmia Challenges in Cardio-Oncology: High-Risk Therapies, Management, and Anticoagulation Ischemic Heart Disease in the Cancer Population: Trends, Outcomes, Epidemiology, and Challenges in Diagnosis and Treatment Cardiovascular Health in Breast Cancer: Survivorship Care Cardiovascular Risk in Prostate Cancer Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic Advances Cardiotoxicity of Anthracyclines Cardiac Complications of Radiation Therapy Cardiac Complications of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy Cardio-oncology Drug Interactions: A Primer for Clinicians on Select Cardiotoxic Oncologic Therapies Cardio-Oncology Program Building: A Practical Guide
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.